CMIC provides accurate evaluation of overseas data for use in the Japanese approval process.
Accurate assessment results based on our expertise and proven successes
Providing reliable data assessment by specialists
- Review by specialized staff
- CMIC's experienced staff is engaged in data analysis.
- Network of inside and outside specialists
- An inside and outside network of professionals in pharmaceutical affairs, medicine, pharmacy, pharmacology, toxicology and quality control supports our clients from every angle.
Feasibility study (assessment and reporting of nonclinical and clinical trial data)
- Whether there are sufficient data for clinical trials
- Whether there are sufficient data for approval application
- Proposal of supplementary data and tests
Support for Drug Master File (DMF) Registration
